Incidental abnormal bone marrow signal on magnetic resonance imaging and reflexive testing for the V617F mutation.
作者信息
Langabeer Stephen E
机构信息
Cancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland.
出版信息
Quant Imaging Med Surg. 2018 Sep;8(8):881-882. doi: 10.21037/qims.2018.08.11.
Abstract
摘要
相似文献
1
Incidental abnormal bone marrow signal on magnetic resonance imaging and reflexive testing for the V617F mutation.
Quant Imaging Med Surg. 2018 Sep;8(8):881-882. doi: 10.21037/qims.2018.08.11.
2
Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals.
Acta Haematol. 2007;118(4):209-14. doi: 10.1159/000111532. Epub 2007 Nov 21.
3
Bone marrow phospho-STAT5 expression in non-CML chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation.
Am J Surg Pathol. 2007 Feb;31(2):233-9. doi: 10.1097/01.pas.0000213338.25111.d3.
4
The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):307-40. doi: 10.1055/s-2006-942754.
5
Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Arch Pathol Lab Med. 2014 Sep;138(9):1203-9. doi: 10.5858/arpa.2013-0018-OA.
6
[Clinical study on relationship between JAK2 V617F mutation and chronic myeloproliferative disorders].
Zhonghua Xue Ye Xue Za Zhi. 2008 Feb;29(2):105-9.
7
Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis.
J Formos Med Assoc. 2012 Jan;111(1):34-40. doi: 10.1016/j.jfma.2012.01.003. Epub 2012 Feb 1.
8
Morphologic and Molecular Characteristics of De Novo AML With V617F Mutation.
J Natl Compr Canc Netw. 2017 Jun;15(6):790-796. doi: 10.6004/jnccn.2017.0106.
9
Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status.
Br J Haematol. 2009 Jul;146(2):150-7. doi: 10.1111/j.1365-2141.2009.07726.x. Epub 2009 May 19.
10
JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
Haematologica. 2008 Jan;93(1):34-40. doi: 10.3324/haematol.11581.
引用本文的文献
1
Potential factors of specialists' willingness to write editorial and commentary: a retrospective study based on 5,091 invitations.
Ann Transl Med. 2019 Dec;7(24):805. doi: 10.21037/atm.2019.12.75.
本文引用的文献
1
Musculoskeletal Imaging Findings of Hematologic Malignancies.
Radiographics. 2017 May-Jun;37(3):881-900. doi: 10.1148/rg.2017160133. Epub 2017 Apr 7.
2
Who to screen for calreticulin mutations? An audit of real-life practice and review of current evidence.
Eur J Intern Med. 2017 May;40:e22-e23. doi: 10.1016/j.ejim.2017.01.020. Epub 2017 Jan 26.
3
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms.
Blood. 2017 Feb 9;129(6):667-679. doi: 10.1182/blood-2016-10-695940. Epub 2016 Dec 27.
4
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
5
Incidence and evaluation of incidental abnormal bone marrow signal on magnetic resonance imaging.
ScientificWorldJournal. 2014;2014:380814. doi: 10.1155/2014/380814. Epub 2014 Oct 14.
6
Incidentally detected diffuse signal alterations of bone marrow on MRI: is bone marrow biopsy indicated?
Neth J Med. 2014 Sep;72(7):345-8.
7
Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations.
Br J Haematol. 2013 Jan;160(1):25-34. doi: 10.1111/bjh.12075. Epub 2012 Oct 11.
8
Uses and abuses of JAK2 and MPL mutation tests in myeloproliferative neoplasms a paper from the 2010 William Beaumont hospital symposium on molecular pathology.
J Mol Diagn. 2011 Sep;13(5):461-6. doi: 10.1016/j.jmoldx.2011.05.007. Epub 2011 Jun 30.
Zotero 插件